Search results
You searched for:
Found 1,337 results
Sorting options:
Date: 01/01/2026 Location: Other
New research is providing more evidence and understanding about the effectiveness and safety of tirzepatide versus semaglutide. Hear from A/Prof Samantha Hocking about this latest study and what it means for prescribing clinicians who are using these agents
0.5 Performance review hour
Addressing health inequities
Professionalism
Culturally safe practice
Ethical practice
Date: 01/01/2026 Location: Other
New research is providing more evidence and understanding about the effectiveness and safety of tirzepatide versus semaglutide. Hear from A/Prof Samantha Hocking about this latest study and what it means for prescribing clinicians who are using these agents
1 Outcome measurement hour
Addressing health inequities
Ethical practice
Culturally safe practice
Professionalism
Date: 01/01/2026 Location: Other
The link between obesity and obstructive sleep apnoea (OSA) is firmly established. And now, with the advent of effective obesity incretin therapies, what does that mean for the management of OSA? And where does that leave CPAP therapy? In this article, OSA
Ethical practice
Professionalism
Addressing health inequities
1 Educational activity hour
Date: 01/01/2026 Location: Other
The link between obesity and obstructive sleep apnoea (OSA) is firmly established. And now, with the advent of effective obesity incretin therapies, what does that mean for the management of OSA? And where does that leave CPAP therapy? In this article, OSA
0.5 Performance review hour
Addressing health inequities
Culturally safe practice
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
The link between obesity and obstructive sleep apnoea (OSA) is firmly established. And now, with the advent of effective obesity incretin therapies, what does that mean for the management of OSA? And where does that leave CPAP therapy? In this article, OSA
1 Outcome measurement hour
Addressing health inequities
Culturally safe practice
Ethical practice
Professionalism
Date: 01/01/2026 Location: Other
For patients with T2D plus cardiovascular disease, multiple risk factors, or chronic kidney disease who cannot take an SGLT2 inhibitor, Australian clinical guidelines recommend prescribing a GLP-1 receptor agonist in addition to other glucose lowering
1 Educational activity hour
1.5 Performance review hours
4 Outcome measurement hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
In Part 1 of this Module you will explore the requirements of valid consent. In Part 2 you will explore when an adult will have capacity to make decisions about medical treatment.
0.75 Educational activity hour
0.25 Performance review hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This module focuses on withholding and withdrawing life-sustaining treatment from adults.
0.5 Educational activity hour
Ethical practice
Professionalism
Date: 01/01/2026 Location: Other
This module explores Advance Care Planning and the law relating to Advance Care Directives, including when an Advance Care Directive can apply, and when it must be followed.
0.75 Educational activity hour
0.25 Performance review hour
Ethical practice
Professionalism
Date: 01/01/2026 Location: Other
This module explores who can be a substitute decisionmaker for an adult, when they can make decisions, how they should make decisions, and when a substitute decision-maker’s decision needs to be followed.
0.25 Educational activity hour
0.25 Performance review hour
Professionalism
Ethical practice